Immunothrombosis Biomarkers and Multi-Omics Profiles After Successful Recanalization in Patients Receiving Ischemic Postconditioning: An Exploratory Analysis of the INSPIRE Trial
Translational Stroke Research · 2026-12 · 17 (6)
DOI: 10.1007/s12975-026-01513-x ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift Translational Stroke Research, online erschienen am 03.11.2026. Verfasst von Yongbo Xu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Huanhu Hospital Affiliated to Tianjin Medical University, Tianjin Medical University, Tianjin, China. Hauptthemen laut MEDLINE: Ischemic Postconditioning, Stroke. Die Arbeit nennt 24 Literaturangaben. Gefördert von: National Health Commission Capacity Building and Continuing Education Center Nervous System and Minimally Invasive Intervention Program, National Natural Science Foundation of China, Tianjin Key Medical Discipline Construction Project.
Abstract (Originalsprache)
Successful recanalization after endovascular thrombectomy does not always restore microvascular perfusion, highlighting the need for adjunctive strategies. Ischemic postconditioning (IPostC) involves brief, controlled cycles of flow interruption and restoration at the onset of reperfusion to attenuate ischemia-reperfusion injury. In the parent INSPIRE trial, IPostC, delivered in situ as four cycles of 2-minute balloon inflation followed by 2-minute deflation at the previously occluded arterial segment immediately after successful recanalization, reduced infarct growth from baseline to 48 h. This exploratory secondary analysis included all 60 randomized patients. We investigated whether IPostC was associated with early changes in immunothrombosis, coagulation, and microvascular transit and explored associated plasma proteomic and metabolomic profiles. Arterial blood obtained approximately 15 min after successful recanalization was analyzed using flow cytometry and thromboelastography. Quantitative digital subtraction angiography–derived microcirculation time was analyzed in 55 patients, and plasma proteomic and metabolomic profiling was performed in 29 patients. Compared with controls, patients receiving IPostC had lower neutrophil CD11b expression (median, 52.15 versus 64.27 mean fluorescence intensity ×10²; P = 0.011), a lower thromboelastography α-angle (65.15° versus 67.95°; P = 0.037), and shorter microcirculation time (2.11 versus 3.03 s; P = 0.020). Longer microcirculation time was associated with greater infarct growth ( r = 0.533; P < 0.001). Proteomic and metabolomic analyses identified signals involving blood–brain barrier and extracellular-matrix organization and mitochondrial bioenergetics. Biomarker comparisons were not adjusted for multiple comparisons; in the omics analyses, no protein and 17 metabolites remained significant after false discovery rate correction. In summary, IPostC was associated with lower neutrophil activation, slower clot propagation, and faster microvascular transit after recanalization, and multi-omics profiling pointed to blood–brain barrier integrity and mitochondrial bioenergetics as candidate pathways. These findings are hypothesis-generating and require validation in larger studies. Trial registration: NCT06545734, registered 9 August 2024.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Huanhu Hospital Affiliated to Tianjin Medical University, Tianjin Medical University, Tianjin, China.
- Department of Neurology, Tianjin Huanhu Hospital, Tianjin, China.
- Department of Clinical Laboratory, Tianjin Huanhu Hospital, Tianjin, China.
- Department of Neurosurgery, Tianjin Huanhu Hospital, Tianjin, China.
- Huanhu Hospital Affiliated to Tianjin Medical University, Tianjin Medical University, Tianjin, China. weiming@tmu.edu.cn.
- Department of Neurosurgery, Tianjin Huanhu Hospital, Tianjin, China. weiming@tmu.edu.cn.
Förderung
- National Health Commission Capacity Building and Continuing Education Center Nervous System and Minimally Invasive Intervention Program
- National Natural Science Foundation of China
- Tianjin Key Medical Discipline Construction Project
- National Health Commission Key Scientific and Technological Project for Stroke Prevention and treatment
- Tianjin Health Science and Technology Key Project
- Ministry of Education Collaborative Innovation Center for Brain Disorders Prevention and Treatment Project
- Tianjin Municipal Education Commission Key Science and Technology Project
Zitieren
APA
Xu, Y., Lu, D., Liu, S., Jiang, X., Wang, Q., Luo, L., Wang, S., Wang, Y., Xu, Z., Wu, Z., & Wei, M. (2026). Immunothrombosis Biomarkers and Multi-Omics Profiles After Successful Recanalization in Patients Receiving Ischemic Postconditioning: An Exploratory Analysis of the INSPIRE Trial. Translational Stroke Research, 17(6). https://doi.org/10.1007/s12975-026-01513-x
Vancouver
Xu Y, Lu D, Liu S, Jiang X, Wang Q, Luo L, et al. Immunothrombosis Biomarkers and Multi-Omics Profiles After Successful Recanalization in Patients Receiving Ischemic Postconditioning: An Exploratory Analysis of the INSPIRE Trial. Translational Stroke Research. 2026;17(6). doi:10.1007/s12975-026-01513-x
BibTeX
@article{Xu2026,
author = {Xu, Yongbo and Lu, Da and Liu, Shuai and Jiang, Xiao and Wang, Qin and Luo, Leilei and Wang, Sifei and Wang, Yilin and Xu, Zhihong and Wu, Ziqing and Wei, Ming},
title = {Immunothrombosis Biomarkers and Multi-Omics Profiles After Successful Recanalization in Patients Receiving Ischemic Postconditioning: An Exploratory Analysis of the INSPIRE Trial},
journal = {Translational Stroke Research},
year = {2026},
volume = {17},
number = {6},
doi = {10.1007/s12975-026-01513-x}
}
EUVIMED